FDA proposes new lead limits for baby food to reduce potential risks to children’s health

FDA proposes new lead limits for baby food to reduce potential risks to children’s health


Jgi/jamie Grill | Tetra Images | Getty Images

The Food and Drug Administration proposed new limits Tuesday on lead in baby food, in an effort to reduce exposure to a toxin that can impair childhood development.

The lead limits apply to processed food consumed by children younger than two years old. In a statement, FDA Commissioner Dr. Robert Califf said the limits would reduce lead exposure from these foods by as much as 27%.

related investing news

Cowen says buy Regeneron, success of drugs could help pharmaceutical stock

CNBC Pro

The proposed lead limits are not legally binding on the industry, but the FDA said it would use them as a factor in deciding whether to take enforcement action against a company for selling contaminated food.

The agency proposed the following lead concentration limits for baby food:

  • 10 parts per billion for fruits, vegetables, yoghurts, custards and puddings, mixtures, and single ingredient meats. This would reduce exposure by 26%.
  • 20 parts per billion for root vegetables. This would reduce exposure by 27%.
  • 20 parts per billion for dry cereals. This would reduce exposure by 24%.

Lead is toxic and particularly dangerous for young children. It can impair brain development and the nervous system, resulting in learning disabilities and behavioral difficulties.

Lead exposure through food among children ages 1 to 3 has declined 97% since the 1980s, according to the FDA. Though progress has been made over the years, the agency launched an effort in 2021 to reduce the levels of lead, arsenic, cadmium and mercury in children’s food to the greatest extent possible.

Food consumed by children can contain lead due to contaminated water or soil, industrial activity and old lead-containing equipment used to make food, according to the FDA. The agency said it’s not possible to completely remove lead from the food supply, but the limits should push industry to take measures to reduce its presence as much as possible.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More